Core Viewpoint - The company plans to use its reserves to offset accumulated losses by the end of 2024, aiming to enhance investor returns and support high-quality development [1][2]. Group 1: Financial Situation - As of December 31, 2024, the company's accumulated losses amount to RMB 1.45 billion, with surplus reserves of RMB 118 million and capital reserves of RMB 6.5767 billion [1]. - The accumulated losses are primarily due to past operational results, and the proposed capital reserve offset will come entirely from shareholder contributions in the form of share premiums [1]. Group 2: Proposed Plan - The company suggests using RMB 118 million from surplus reserves and RMB 1.332 billion from capital reserves to fully offset the accumulated losses, totaling RMB 1.45 billion [1]. - After the completion of the loss offset plan, surplus reserves will be reduced to RMB 0, capital reserves will decrease to RMB 5.245 billion, and accumulated losses will be fully eliminated [2].
康希诺生物拟使用公积金弥补亏损